Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Alpha-synuclein dimerization in erythrocytes of patients with genetic and non-genetic forms of Parkinson's Disease.

Neuroscience letters - 13 Apr 2018

Papagiannakis Nikolaos, Koros Christos, Stamelou Maria, Simitsi Athina-Maria, Maniati Matina, Antonelou Roubina, Papadimitriou Dimitra, Dermentzaki Georgia, Moraitou Marina, Michelakakis Helen, Stefanis Leonidas

Abstract excerpt

BACKGROUND: Variations of α-synuclein levels or species have been reported in Parkinson's Disease (PD). There has been little systematic examination of erythrocytes, a rich source of α-synuclein. METHODS: Erythrocyte membranes were obtained from PD patients (mutation carriers in the α-synuclein gene (A53T-PD) and glucocerebrosidase gene (GBA-PD) (n=18 each), and patients without known mutations (GU-PD, n=56)),...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to alpha-Synuclein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Dimerization

Share to Erythrocytes

Share to Glucosylceramidase

Share to Mutation

Share to Parkinson Disease

Share to Parkinson's Disease Mechanisms and Treatments

Source

Identifiers

PMID: 29129675
DOI: 10.1016/j.neulet.2017.11.012

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Alpha-synuclein dimerization in erythrocytes of patients with genetic and non-genetic forms of Parkinson's Disease.PMID 29129675Read ↗

Aggregated α-synuclein in erythrocytes as a potential biomarker for idiopathic Parkinson's DiseaseSemantic proximity Read ↗

Erythrocytic α-Synuclein as a potential biomarker for Parkinson’s diseaseSemantic proximity Read ↗

Erythrocytic α-Synuclein Species for Parkinson’s Disease Diagnosis and the Correlations With Clinical CharacteristicsSemantic proximity Read ↗

Alterations of Erythrocytic Phosphorylated Alpha-Synuclein in Different Subtypes and Stages of Parkinson's DiseaseSemantic proximity Read ↗

Alpha-synuclein is increased in erythrocytes in Parkinson’s Disease casesSemantic proximity Read ↗

Aggregation-resistant alpha-synuclein tetramers are reduced in the blood of Parkinson’s patientsSemantic proximity Read ↗

Polymorphism in alpha-synuclein oligomers and its implications in toxicity under disease conditionsSemantic proximity Read ↗

Aggregation of α-synuclein in brain samples from subjects with glucocerebrosidase mutations.Semantic proximity Read ↗

Reduced content of α-synuclein in peripheral blood leukocytes of patients with LRRK2-associated Parkinson's disease.Semantic proximity Read ↗

α-Synuclein in central nervous system and from erythrocytes, mammalian cells, and Escherichia coli exists predominantly as disordered monomer.Semantic proximity Read ↗

Combined measure of salivary alpha-synuclein species as diagnostic biomarker for Parkinson’s diseaseSemantic proximity Read ↗

[Plasma Exosomes in Inherited Forms of Parkinson's Disease].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.